Shares of Catalent are down 21% or $13.31 at $50.00 in pre-market trading after the company stated that "productivity issues and higher-than-expected costs experienced at three of its facilities, including two of its largest manufacturing facilities, during the quarter will materially and adversely impact the company’s financial results for the third fiscal quarter and its outlook for the remainder of the 2023 fiscal year."
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CTLT:
- Catalent Tanks on Productivity Challenges at Three Facilities
- Catalent names Ricky Hopson interim CFO, announces adverse impact to Q3 results
- Sarepta sinks after STAT says FDA leaned against gene therapy approval
- Catalent upgraded to Buy from Hold at Deutsche Bank
- Catalent downgraded to Equal Weight from Overweight at Barclays